CLINICAL GUIDELINES

NASS encourages widespread circulation and implementation of the evidence-based recommendations made in NASS guidelines. To this end, NASS supports responsible translation of its clinical practice guidelines into other languages. NASS strongly encourages use of appropriately trained translators with an excellent knowledge of the English language, an excellent knowledge of the target language, significant experience in both languages, cultures and medicine, and ideally some content knowledge.

It is also strongly recommended that translators implement a rigorous procedure for verifying the accuracy of translations via a multiple forward translation process or a back-translation process with careful comparisons between documents. Individuals interested in translating guidelines are granted permission to do so, provided the resulting publication follows these requirements:

• The document carries the NASS disclaimers listed below.
• The document clearly indicates the version of the guideline being translated either by version number or date of publication by NASS.
• No fees are charged above those charges necessary to recoup the cost of translation.

Any translations of the NASS clinical practice guidelines should carry the following disclaimers listed below.

Reprinted and translated with the permission of NASS. NASS does not verify, certify and is not responsible for the accuracy of any translations, and has advised any parties translating the NASS clinical practice guidelines to carefully verify the accuracy of their translations prior to publication and dissemination.

This clinical guideline should not be construed as including all proper methods of care or excluding other acceptable methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient and the needs and resources particular to the locality or institution.